betamethasone 0.001 MG/MG Topical Ointment
- RxCUI
- 197409
- RxNorm name
- betamethasone 0.001 MG/MG Topical Ointment
- Display name
- Betamethasone (Topical)
- Full name
- betamethasone 0.001 MG/MG Topical Ointment
- Term type
- SCD
- Status
- Active
- Strength
- 0.1%
- Dose form
- Ointment
- Route
- Topical
- Updated
- 2026-11-02 18:17:56
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| betamethasone valerate | 0.001 MG / 1 MG | betamethasone | betamethasone |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Ointment | 316985 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| betamethasone | 1514 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | betamethasone 0.001 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Name | betamethasone 0.001 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 4 | CODES | |
| RxCUI | 197409 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0168-0033-15 | 0168-0033 | Betamethasone Valerate betamethasone valerate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | NDA018865 |
| 0168-0033-46 | 0168-0033 | Betamethasone Valerate betamethasone valerate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | NDA018865 |
| 0713-0327-15 | 0713-0327 | Betamethasone Valerate Betamethasone Valerate | Cosette Pharmaceuticals, Inc. | ANDA070069 |
| 0713-0327-37 | 0713-0327 | Betamethasone Valerate Betamethasone Valerate | Cosette Pharmaceuticals, Inc. | ANDA070069 |
| 68788-8496-1 | 68788-8496 | Betamethasone Valerate betamethasone valerate | Preferred Pharmaceuticals Inc. | NDA018865 |
| 68788-8496-4 | 68788-8496 | Betamethasone Valerate betamethasone valerate | Preferred Pharmaceuticals Inc. | NDA018865 |
| 71205-364-15 | 71205-364 | Betamethasone Valerate Betamethasone Valerate | Proficient Rx LP | ANDA070069 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| NDA018865 | 0168-0033 | Betamethasone Valerate betamethasone valerate | NDA | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC |
| ANDA070069 | 0713-0327 | Betamethasone Valerate Betamethasone Valerate | ANDA | Cosette Pharmaceuticals, Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 50d4763d-5a84-4c45-be06-040c4a527470 | 2026-03-19 | Adverse reactions | 68788-8496-1 68788-8496-4 68788-8496 68788849601 68788849604 197409 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 0b386ccc-a2d4-4d18-a2d7-e46ff894c674 | 2026-01-28 | Adverse reactions | 0168-0033-46 0168-0033-15 0168-0033 00168003346 00168003315 197409 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Cosette Pharmaceuticals, Inc. | 784476d2-5e5c-fdba-a677-8973a777b5ef | 2022-05-05 | Adverse reactions | 0713-0327-15 0713-0327-37 0713-0327 00713032737 00713032715 197409 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 2a64b65b-8a49-45ea-9464-2269751c075c | 2021-04-01 | Adverse reactions | 71205-364-15 71205-364 71205036415 197409 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0b386ccc-a2d4-4d18-a2d7-e46ff894c674 | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 10 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | 20260128 |
| 784476d2-5e5c-fdba-a677-8973a777b5ef | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 9 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | 20220505 |
| 50d4763d-5a84-4c45-be06-040c4a527470 | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 5 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | 20260319 |
| 2a64b65b-8a49-45ea-9464-2269751c075c | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 2 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | 20210401 |
| 1e19dd44-06a9-03bc-e063-6294a90a3a31 | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 1 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | 20240725 |
| 3cd0f7e2-e1bc-4ec7-91d3-58dfe37b04b5 | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 1 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | 20220330 |
| eeb337ba-0d7e-42cd-840a-78783b5688d7 | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 1 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | 20100922 |
| 72bcd320-39d6-49db-bc7b-d140d200076a | betamethasone valerate 0.1 % Topical Ointment [PSN] · betamethasone 0.001 MG/MG Topical Ointment [SCD] · betamethasone 0.1 % Topical Ointment [SY] · betamethasone 1 MG/GM (as betamethasone valerate 1.2 MG/GM) Topical Ointment [SY] | 4 | 1 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | 20091023 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 50d4763d-5a84-4c45-be06-040c4a527470 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | Preferred Pharmaceuticals Inc. | 20260319 |
| 0b386ccc-a2d4-4d18-a2d7-e46ff894c674 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 20260128 |
| 9a1daee5-ab2e-413c-9e36-dd1824bbbc52 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | RPK Pharmaceuticals, Inc. | 20241219 |
| 1e19dd44-06a9-03bc-e063-6294a90a3a31 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | RedPharm Drug | 20240725 |
| c95d2fdd-10f2-4bbf-9655-9ac7a7232c28 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | Preferred Pharmaceuticals, Inc. | 20240311 |
| 784476d2-5e5c-fdba-a677-8973a777b5ef | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | Cosette Pharmaceuticals, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC | 20220505 |
| 3cd0f7e2-e1bc-4ec7-91d3-58dfe37b04b5 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | RPK Pharmaceuticals, Inc. | 20220330 |
| 2a64b65b-8a49-45ea-9464-2269751c075c | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% (Potency expressed as betamethasone) Rx only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. | Proficient Rx LP | 20210401 |
| f23754dc-fcb1-401f-a781-d7d1f7c07ceb | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | Preferred Pharmaceuticals Inc. | 20200407 |
| 7fc14c26-2cad-43c5-82c7-ced4cc845292 | BETAMETHASONE VALERATE CREAM, USP 0.1% BETAMETHASONE VALERATE OINTMENT, USP 0.1% | Proficient Rx LP | 20191101 |
| 7918aa75-1786-4155-92b6-069efcce226e | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | A-S Medication Solutions | 20171219 |
| adad8824-bf2e-463d-9609-87b960801eee | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% | Actavis Pharma, Inc. | 20161130 |
| a42239e9-0c73-4dbd-a2db-95d5ff6a1e33 | National Council for Prescription Drug Programs | 20130303 | |
| 07944208-5f7c-47f6-ba1f-3bfcbf26cf0f | National Council for Prescription Drug Programs | 20130303 | |
| 71f4df2d-2793-4161-9dee-ec3928d62733 | National Council for Prescription Drug Programs | 20120724 | |
| 6a2d5506-ec86-4e5d-ae5b-b33722a81aaf | National Council for Prescription Drug Programs | 20120724 | |
| 6902e168-0973-4469-8349-10d58a66d243 | National Council for Prescription Drug Programs | 20120724 | |
| 53a6ff13-d79f-4486-8858-c8cbd45b490a | National Council for Prescription Drug Programs | 20120724 | |
| eeb337ba-0d7e-42cd-840a-78783b5688d7 | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | Rebel Distributors Corp | 20100922 |
| 72bcd320-39d6-49db-bc7b-d140d200076a | BETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone) | Physicians Total Care, Inc. | 20091023 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C05AA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S03BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S02BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | R01AD | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | betamethasone | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | betamethasone | |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | betamethasone | |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | betamethasone | |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | betamethasone | |
| ATC | R03BA | Glucocorticoids | ATC1-4 | betamethasone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | betamethasone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.001 MG/MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA070069 |
| CODES | NDA | NDA018865 |
| CODES | SNOMEDCT | 396279000 |
| CODES | SNOMEDCT | 785081007 |
| CODES | VUID | 4005800 |
| NAMES | Prescribable Synonym | betamethasone valerate 0.1 % Topical Ointment |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |